PMC:7376845 / 569-785 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T4","span":{"begin":168,"end":175},"obj":"Body_part"}],"attributes":[{"id":"A4","pred":"fma_id","subj":"T4","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"which interacts with ACE2, appear conserved in SARS-CoV-2.\n\nAim\nThe cross-reactivity with SARS-CoV-2 of monoclonal antibodies (mAbs) previously generated against the S protein of SARS-CoV-1 was assessed.\n\nMethods\nThe"}

{"project":"LitCovid-PubTator","denotations":[{"id":"20","span":{"begin":21,"end":25},"obj":"Gene"},{"id":"27","span":{"begin":47,"end":57},"obj":"Species"},{"id":"33","span":{"begin":166,"end":167},"obj":"Gene"},{"id":"34","span":{"begin":179,"end":187},"obj":"Species"},{"id":"35","span":{"begin":90,"end":100},"obj":"Species"}],"attributes":[{"id":"A20","pred":"tao:has_database_id","subj":"20","obj":"Gene:59272"},{"id":"A27","pred":"tao:has_database_id","subj":"27","obj":"Tax:2697049"},{"id":"A33","pred":"tao:has_database_id","subj":"33","obj":"Gene:43740568"},{"id":"A34","pred":"tao:has_database_id","subj":"34","obj":"Tax:694009"},{"id":"A35","pred":"tao:has_database_id","subj":"35","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"which interacts with ACE2, appear conserved in SARS-CoV-2.\n\nAim\nThe cross-reactivity with SARS-CoV-2 of monoclonal antibodies (mAbs) previously generated against the S protein of SARS-CoV-1 was assessed.\n\nMethods\nThe"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T17","span":{"begin":47,"end":55},"obj":"Disease"},{"id":"T18","span":{"begin":47,"end":51},"obj":"Disease"},{"id":"T19","span":{"begin":90,"end":98},"obj":"Disease"},{"id":"T20","span":{"begin":90,"end":94},"obj":"Disease"},{"id":"T21","span":{"begin":179,"end":187},"obj":"Disease"},{"id":"T22","span":{"begin":179,"end":183},"obj":"Disease"}],"attributes":[{"id":"A17","pred":"mondo_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A18","pred":"mondo_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A19","pred":"mondo_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A20","pred":"mondo_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A21","pred":"mondo_id","subj":"T21","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A22","pred":"mondo_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"which interacts with ACE2, appear conserved in SARS-CoV-2.\n\nAim\nThe cross-reactivity with SARS-CoV-2 of monoclonal antibodies (mAbs) previously generated against the S protein of SARS-CoV-1 was assessed.\n\nMethods\nThe"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T7","span":{"begin":60,"end":63},"obj":"http://purl.obolibrary.org/obo/PR_000001343"}],"text":"which interacts with ACE2, appear conserved in SARS-CoV-2.\n\nAim\nThe cross-reactivity with SARS-CoV-2 of monoclonal antibodies (mAbs) previously generated against the S protein of SARS-CoV-1 was assessed.\n\nMethods\nThe"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T5","span":{"begin":168,"end":175},"obj":"Chemical"}],"attributes":[{"id":"A5","pred":"chebi_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"which interacts with ACE2, appear conserved in SARS-CoV-2.\n\nAim\nThe cross-reactivity with SARS-CoV-2 of monoclonal antibodies (mAbs) previously generated against the S protein of SARS-CoV-1 was assessed.\n\nMethods\nThe"}

{"project":"LitCovid-sentences","denotations":[{"id":"T7","span":{"begin":60,"end":63},"obj":"Sentence"},{"id":"T8","span":{"begin":64,"end":203},"obj":"Sentence"},{"id":"T9","span":{"begin":205,"end":212},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"which interacts with ACE2, appear conserved in SARS-CoV-2.\n\nAim\nThe cross-reactivity with SARS-CoV-2 of monoclonal antibodies (mAbs) previously generated against the S protein of SARS-CoV-1 was assessed.\n\nMethods\nThe"}